Plain-English translation of NCT06505564 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing AVATAR therapy, a virtual reality treatment designed to help reduce auditory hallucinations (hearing voices) in people with schizophrenia spectrum disorder whose symptoms persist despite being on stable medications. The therapy uses VR technology to safely simulate and help you practice coping with the voices you hear, with support from a trained therapist. The goal is to decrease how often and how intensely you experience these voices, and to improve related anxiety and depression.
Many people with schizophrenia continue to hear distressing voices even when taking antipsychotic medications. This treatment aims to fill that gap by offering a specialized therapy that directly addresses the voices and helps patients develop better ways to cope with them.
You will first wait 12 weeks (this is a control period to measure your baseline symptoms), then receive 7 individual therapy sessions over 12 weeks, with each session lasting about 50 minutes. During these sessions, you'll wear a VR headset while a trained therapist helps you practice responding to the voices in a safe, simulated environment. You'll complete assessments before waiting, before treatment begins, and after treatment ends to measure changes in your symptoms and quality of life.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Hungary
Poland
Spain